L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 232
- Registration Number
- NCT03062150
- Locations
- 🇩🇪
Charité Universitätsmedizin Berlin, Berlin, Germany
D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Boston University Charles River Campus
- Target Recruit Count
- 56
- Registration Number
- NCT02983734
- Locations
- 🇺🇸
Boston University, Boston, Massachusetts, United States
D-Cycloserine and Virtual Reality Exposure Therapy
- Conditions
- Interventions
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- Georgia State University
- Registration Number
- NCT02933684
- Locations
- 🇺🇸
Georgia State University, Atlanta, Georgia, United States
D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
- Conditions
- Interventions
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02772211
- Locations
- 🇮🇱
Psychiatry Clinic - Sheba Medical Center, Ramat-Gan, Israel
Glutamate, Learning, and Working Memory
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 110
- Registration Number
- NCT02769936
Cycloserine in the Treatment of Sleep Apnea
- First Posted Date
- 2016-04-13
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 18
- Registration Number
- NCT02735694
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
🇨🇦Sleep Disorders Centre, Winnipeg, Manitoba, Canada
Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?
- Conditions
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Haukeland University Hospital
- Target Recruit Count
- 163
- Registration Number
- NCT02656342
- Locations
- 🇳🇴
Akershus University Hospital, Lorenskog, Norway
🇳🇴Sykehuset i Vestfold, Tonsberg, Norway
🇳🇴Stavanger University Hospital, Stavanger, Norway
Lower Limb Function After Spinal Cord Injury
- Conditions
- Interventions
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- Shirley Ryan AbilityLab
- Target Recruit Count
- 257
- Registration Number
- NCT02635893
- Locations
- 🇺🇸
The Shirley Ryan Ability Lab, Chicago, Illinois, United States
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
- Conditions
- Interventions
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2019-04-25
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT02582515
- Locations
- 🇺🇸
UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States
Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
- Conditions
- Interventions
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 24
- Registration Number
- NCT02385266
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.